Differential effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLoS One, volume 8, issue 11, e80070 (2013)
- Keyword
-
Endokrinologie
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Univ.-Bibliothek Frankfurt am Main
- (when)
-
2013
- Contributor
-
Badura, Susanne
Tešanović, Tamara
Pfeifer, Heike
Wystub, Sylvia
Nijmeijer, Bart A.
Liebermann, Marcus
Falkenburg, J. H. Frederik
Ruthardt, Martin
Ottmann, Oliver G.
- URN
-
urn:nbn:de:hebis:30:3-324223
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Badura, Susanne
- Tešanović, Tamara
- Pfeifer, Heike
- Wystub, Sylvia
- Nijmeijer, Bart A.
- Liebermann, Marcus
- Falkenburg, J. H. Frederik
- Ruthardt, Martin
- Ottmann, Oliver G.
- Univ.-Bibliothek Frankfurt am Main
Time of origin
- 2013
Other Objects (12)
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
Acute lymphoblastic leukemia
Cardiac manifestation of acute lymphoblastic leukemia
Prognostic impact of leukemia biology in pediatric acute lymphoblastic leukemia
Infection-related complications in paediatric acute lymphoblastic leukemia
The PI3K Pathway: Background and Treatment Approaches
Genetic variants in susceptibility to childhood acute lymphoblastic leukemia
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia
α4 integrin-mediated anoikis in acute lymphoblastic leukemia cells
Preclinical evaluation of sensitivity and predictive biomarkers for selective BCL-2 family inhibitors in pediatric acute lymphoblastic leukemia
Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia
Characterization of hematopoietic and leukemia stem cells in adult B precursor acute lymphoblastic leukemia
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
Acute lymphoblastic leukemia
Cardiac manifestation of acute lymphoblastic leukemia
Prognostic impact of leukemia biology in pediatric acute lymphoblastic leukemia
Infection-related complications in paediatric acute lymphoblastic leukemia
The PI3K Pathway: Background and Treatment Approaches
Genetic variants in susceptibility to childhood acute lymphoblastic leukemia
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia
α4 integrin-mediated anoikis in acute lymphoblastic leukemia cells
Preclinical evaluation of sensitivity and predictive biomarkers for selective BCL-2 family inhibitors in pediatric acute lymphoblastic leukemia
Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia
Characterization of hematopoietic and leukemia stem cells in adult B precursor acute lymphoblastic leukemia
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia
Acute lymphoblastic leukemia
Cardiac manifestation of acute lymphoblastic leukemia
Prognostic impact of leukemia biology in pediatric acute lymphoblastic leukemia
Infection-related complications in paediatric acute lymphoblastic leukemia
The PI3K Pathway: Background and Treatment Approaches
Genetic variants in susceptibility to childhood acute lymphoblastic leukemia
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia
α4 integrin-mediated anoikis in acute lymphoblastic leukemia cells
Preclinical evaluation of sensitivity and predictive biomarkers for selective BCL-2 family inhibitors in pediatric acute lymphoblastic leukemia
Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia